NEMF

Chr 14

nuclear export mediator factor

Also known as: IDDSAPN, NY-CO-1, RQC2, SDCCAG1

This gene encodes a component of the ribosome quality control complex. The encoded protein facilitates the recognition and ubiquitination of stalled 60S subunits by the ubiquitin ligase listerin. A similar protein in fly functions as a tumor suppressor. [provided by RefSeq, Jul 2016]

ResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.41
Clinical SummaryNEMF
🧬
Gene-Disease Validity (ClinGen)
intellectual developmental disorder with speech delay and axonal peripheral neuropathy · ARStrong

Strong evidence — appropriate for clinical testing

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.29) despite low pLI — interpret in context.
📋
ClinVar Variants
29 unique Pathogenic / Likely Pathogenic· 145 VUS of 242 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.41LOEUF
pLI 0.000
Z-score 5.63
OE 0.29 (0.200.41)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.19Z-score
OE missense 0.86 (0.790.93)
470 obs / 548.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.29 (0.200.41)
00.351.4
Missense OE?0.86 (0.790.93)
00.61.4
Synonymous OE?1.11
01.21.6
LoF obs/exp: 21 / 72.9Missense obs/exp: 470 / 548.1Syn Z: -1.13

This gene — mechanism propensity

DN
0.6260th %ile
GOF
0.4777th %ile
LOF
0.3261th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and loss-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
LOF93% of P/LP variants are LoF · LOEUF 0.41

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

242 submitted variants in ClinVar

Classification Summary

Pathogenic19
Likely Pathogenic10
VUS145
Likely Benign28
Benign7
19
Pathogenic
10
Likely Pathogenic
145
VUS
28
Likely Benign
7
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
18
1
0
0
19
Likely Pathogenic
9
1
0
0
10
VUS
2
142
1
0
145
Likely Benign
0
6
3
19
28
Benign
0
0
4
3
7
Total29150822209

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

8 pathogenic / likely-pathogenic (of 11) ClinVar copy-number / structural variants overlap NEMF — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

NEMF · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →